07th week of 2017 patent applcation highlights part 21 |
Patent application number | Title | Published |
20170044087 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLATE ACID COMPOUNDS | 2017-02-16 |
20170044088 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED (METH)ACRYLIC ACID COMPOUNDS | 2017-02-16 |
20170044089 | ANAEROBIC CURABLE COMPOSITIONS CONTAINING BLOCKED DICARBOXYLIC ACID COMPOUNDS | 2017-02-16 |
20170044090 | Ring Opening Of Epoxidized Fatty Acid Esters | 2017-02-16 |
20170044091 | COMPOSITION CONTAINING 3-CHLORO-4-METHOXYBENZYLAMINE HYDROCHLORIDE, AND METHOD FOR PRODUCING SAME | 2017-02-16 |
20170044092 | NOVEL CANNABIDIOL QUINONE DERIVATIVES | 2017-02-16 |
20170044093 | LED PHOTOINITIATORS | 2017-02-16 |
20170044094 | PROCESS FOR PREPARING BIPHENYLAMINES FROM ANILIDES BY RUTHENIUM CATALYSIS | 2017-02-16 |
20170044095 | COMPOUNDS FOR THE TREATMENT OF SEIZURES AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS AND CONDITIONS | 2017-02-16 |
20170044096 | Augmenting Moieties for Anti-Inflammatory Compounds | 2017-02-16 |
20170044097 | ANTIBACTERIALS AND/OR MODULATORS OF BIOFILM FORMATION AND METHODS OF USING THE SAME | 2017-02-16 |
20170044098 | Heterodimers of Glutamic Acid | 2017-02-16 |
20170044099 | COVALENTLY PATTERNED GRAPHENE SURFACES BY A FORCE ACCELERATED CYCLOADDITION REACTION | 2017-02-16 |
20170044100 | INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2017-02-16 |
20170044101 | SALTS OF AN LSD1 INHIBITOR | 2017-02-16 |
20170044102 | New Method for Preparing Isofagomine and Its Derivatives | 2017-02-16 |
20170044103 | ANTI-VASCULATURE AND ANTI-TUBULIN COMBRETASTATIN ANALOGS FOR TREATMENT OF CANCER | 2017-02-16 |
20170044104 | NEW PESTICIDAL COMPOUNDS AND USES | 2017-02-16 |
20170044105 | PROCESS FOR THE PREPARATION OF 4-ALKOXY-3-HYDROXYPICOLINIC ACIDS | 2017-02-16 |
20170044106 | Crystalline Solid Forms of N--N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, Processes for Making, and Methods of Use | 2017-02-16 |
20170044107 | Inhibitors of JMJD2C as Anticancer Agents | 2017-02-16 |
20170044108 | S-Crystal Form of Ivabradine Hydrochloride, and Preparation Method and Pharmaceutical Composition Thereof | 2017-02-16 |
20170044109 | SULFONYL HYDRAZIDE COMPOUNDS AND A REGIO-SELECTIVE PROCESS TO PREPARE 4-AROYL PYRAZOLE DERIVATIVES | 2017-02-16 |
20170044110 | Pyrimidine Compounds and Use as Anti-Cervical Cancer Thereof | 2017-02-16 |
20170044111 | JANUS KINASE INHIBITORS AND USES THEREOF | 2017-02-16 |
20170044112 | HYDROPHOBICALLY TAGGED JANUS KINASE INHIBITORS AND USES THEREOF | 2017-02-16 |
20170044113 | NOVEL ALKYLATED DIPHENYLAMINE DERIVATIVES OF TRIAZOLE AND LUBRICATING COMPOSITIONS CONTAINING THE SAME | 2017-02-16 |
20170044114 | Diaminotriazine compounds and their use as herbicides | 2017-02-16 |
20170044115 | NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND | 2017-02-16 |
20170044116 | PROCESS FOR THE PREPARATION OF SUBSTITUTED CYCLOSERINES | 2017-02-16 |
20170044117 | SEMICARBAZIDE-SENSITIVE AMINE OXIDASE INHIBITORS FOR USE AS ANALGESICS IN TRAUMATIC NEUROPATHY AND NEUROGENIC INFLAMMATION | 2017-02-16 |
20170044118 | SALT COMPOUND | 2017-02-16 |
20170044119 | 2,2'-TANDEM DITHIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 2017-02-16 |
20170044120 | ORGANO-1-OXA-4-AZONIUM CYCLOHEXANE COMPOUNDS | 2017-02-16 |
20170044121 | TETRA-O-SUBSTITUTED BUTANE-BRIDGE MODIFIED NDGA DERIVATIVES, THEIR SYNTHESIS AND PHARMAECUTICAL USE | 2017-02-16 |
20170044122 | Oxaspiro[2.5]Octane Derivatives and Analogs | 2017-02-16 |
20170044123 | SYNTHESIS OF R-GLUCOSIDES, SUGAR ALCOHOLS, REDUCED SUGAR ALCOHOLS, AND FURAN DERIVATIVES OF REDUCED SUGAR ALCOHOLS | 2017-02-16 |
20170044124 | BIOREFINING COMPOUNDS AND ORGANOCATALYTIC UPGRADING METHODS | 2017-02-16 |
20170044125 | Catalytic Converter Arrangement with Optimized Surface for Producing Phthalic Anhydride | 2017-02-16 |
20170044126 | PROCESS FOR MAKING BERAPROST | 2017-02-16 |
20170044127 | ICARIIN DERIVATIVES | 2017-02-16 |
20170044128 | Carbonated Estolides And Methods Of Making And Using The Same | 2017-02-16 |
20170044129 | METHOD FOR PREPARING CANAGLIFLOZIN INTERMEDIATE 2-(2-METHYL-5-BROMOBENZYL)-5-(4-FLUOROPHENYL)THIOPHENE | 2017-02-16 |
20170044130 | AGONISTS THAT ENHANCE BINDING OF INTEGRIN-EXPRESSING CELLS TO INTEGRIN RECEPTORS | 2017-02-16 |
20170044131 | TRIAZOLE AGONISTS OF THE APJ RECEPTOR | 2017-02-16 |
20170044132 | HETEROCYCLIC COMPOUND | 2017-02-16 |
20170044133 | NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF | 2017-02-16 |
20170044134 | PROCESS FOR THE PREPARATION OF 3-(3-CHLORO-1H-PYRAZOL-1-YL)PYRIDINE | 2017-02-16 |
20170044135 | PROCESS FOR PREPARING 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-A][1,4]BENZODIAZE- PINE-4-YL]PROPIONIC ACID METHYL ESTER OR THE BENZENE SULFONATE SALT THEREOF, AND COMPOUNDS USEFUL IN THAT PROCESS | 2017-02-16 |
20170044136 | Pyridinoylpiperidines As 5-HT1F Agonists | 2017-02-16 |
20170044137 | Omeprazole sodium semihydrate and preparation method thereof | 2017-02-16 |
20170044138 | CGRP RECEPTOR ANTAGONISTS | 2017-02-16 |
20170044139 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2017-02-16 |
20170044140 | BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2017-02-16 |
20170044141 | ALKYNE-, AZIDE- AND TRIAZOLE-CONTAINING FLAVONOIDS AS MODULATORS FOR MULTIDRUG RESISTANCE IN CANCERS | 2017-02-16 |
20170044142 | NOVEL COMPLEXES FOR THE SEPARATION OF CATIONS | 2017-02-16 |
20170044143 | ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASE | 2017-02-16 |
20170044144 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | 2017-02-16 |
20170044145 | MORPHOLIN-PYRIDINE DERIVATIVES | 2017-02-16 |
20170044146 | GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | 2017-02-16 |
20170044147 | GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | 2017-02-16 |
20170044148 | GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | 2017-02-16 |
20170044149 | PHARMACEUTICAL SALTS OF AN OREXIN RECEPTOR ANTAGONIST | 2017-02-16 |
20170044150 | IDENTIFICATION OF COMPOUNDS WHICH INHIBIT ATG8-ATG3 PROTEIN-PROTEIN INTERACTION AND THEIR USE AS ANTIPARASITICAL AGENTS | 2017-02-16 |
20170044151 | 2-Amino-3-Fluoro-3-(Fluoromethyl)-6-Methyl-6-Phenyl-3,4,5,6-Tetrahydropyri- dines as BACE1 Inhibitors | 2017-02-16 |
20170044152 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | 2017-02-16 |
20170044153 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | 2017-02-16 |
20170044154 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | 2017-02-16 |
20170044155 | Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors | 2017-02-16 |
20170044156 | SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND MEDICINAL USE THEREOF AS HIV INTEGRASE INHIBITOR | 2017-02-16 |
20170044157 | NEW COMPOUNDS I | 2017-02-16 |
20170044158 | DIFLUOROMETHYLENE COMPOUND | 2017-02-16 |
20170044159 | 7-OXO-1,6-DIAZABICYCLO[3.2.1 ]OCTANE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | 2017-02-16 |
20170044160 | TETRACYCLINE COMPOUNDS | 2017-02-16 |
20170044161 | TRICYCLIC COMPOUND AND JAK INHIBITOR | 2017-02-16 |
20170044162 | Fused Pyrimidine-Based Hydroxamate Derivatives | 2017-02-16 |
20170044163 | CGRP RECEPTOR ANTAGONISTS | 2017-02-16 |
20170044164 | BICYCLIC FUSED PYRIMIDINE COMPOUNDS AS TAM INHIBITORS | 2017-02-16 |
20170044165 | PENTYLENETETRAZOLE DERIVATIVES | 2017-02-16 |
20170044166 | NOVEL SALT OF FUSED PYRIMIDINE COMPOUND AND CRYSTAL THEREOF | 2017-02-16 |
20170044167 | SUBSTITUTED 2,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE AND 4,5,6,7-TETRAHYDRO-2H-PYRAZOLO[4,3-C]PYRIDINE COMPOUNDS AS GLYT1 INHIBITORS | 2017-02-16 |
20170044168 | COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS | 2017-02-16 |
20170044169 | Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases | 2017-02-16 |
20170044170 | SOLID FORMS COMPRISING 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF | 2017-02-16 |
20170044171 | COMPOUNDS FOR PREPARING PYRROLE SIX-MEMBERED HETEROARYL RING DERIVATIVE | 2017-02-16 |
20170044172 | SPIRO UREA COMPOUNDS AS RSV ANTIVIRAL COMPOUNDS | 2017-02-16 |
20170044174 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS | 2017-02-16 |
20170044175 | INHIBITORS OF LATE SV40 FACTOR (LSF) AS CANCER CHEMOTHERAPEUTICS | 2017-02-16 |
20170044177 | METHODS AND SYSTEMS FOR PRODUCING ISOSORBIDE FROM BIOMASS | 2017-02-16 |
20170044178 | POLYISOCYANATES FROM FUSED BICYCLIC POLYOLS AND POLYURETHANES THEREFROM | 2017-02-16 |
20170044179 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | 2017-02-16 |
20170044180 | Sesquiterpenoids | 2017-02-16 |
20170044181 | COMPOUNDS FOR TREATING VIRAL INFECTIONS | 2017-02-16 |
20170044182 | FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF | 2017-02-16 |
20170044183 | FACTOR XIa INHIBITORS | 2017-02-16 |
20170044184 | NEW CRYSTAL FORM OF CEFATHIAMIDINE COMPOUND AND PREPARATION METHOD THEREFOR | 2017-02-16 |
20170044185 | Histone Deacetylase Inhibitors and Methods for Use Thereof | 2017-02-16 |
20170044186 | HISTONE DEACETYLASE INHIBITORS | 2017-02-16 |
20170044187 | 1-(3-AMINOPROPYL) SUBSTITUTED CYCLIC AMINE COMPOUNDS, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | 2017-02-16 |
20170044188 | COPPER COMPOUND, STARTING MATERIAL FOR FORMING THIN FILM, AND METHOD FOR MANUFACTURING THIN FILM | 2017-02-16 |